Abstract
BACKGROUND—Dystrophic epidermolysis bullosa (DEB) is an uncommon genetic disorder of the skin and mucosae. In 1996, we reported the occurrence of lethal dilated cardiomyopathy (DCM) in two affected children. METHODS—In the past seven years we have routinely screened patients with severe DEB who have been under the care of this hospital by yearly clinical review, echocardiography, and quantification of plasma selenium and carnitine concentrations, as deficiency of these micronutrients is known to be associated with the development of DCM. RESULTS—Six of 61 children have developed DCM over the seven year period of this study, four of whom have not been previously reported, and three of whom have since died. We compared the concentrations of selenium and free and total carnitine in the children who developed DCM to concentrations in those with severe DEB who did not. The concentrations of free and total carnitine when first measured were significantly lower in the children with DCM, but the selenium concentrations were not. CONCLUSIONS—We now believe that DCM is a not infrequent complication of severe recessive DEB, and may be related in part to carnitine concentrations, though the exact mechanism remains unclear. We therefore recommend that patients with this condition should undergo regular cardiac review including echocardiography.
Full Text
The Full Text of this article is available as a PDF (138.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999 Dec;56(12):1073–1086. doi: 10.1001/archpsyc.56.12.1073. [DOI] [PubMed] [Google Scholar]
- Attas M., Hanley H. G., Stultz D., Jones M. R., McAllister R. G. Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation. 1978 Sep;58(3 Pt 1):566–572. doi: 10.1161/01.cir.58.3.566. [DOI] [PubMed] [Google Scholar]
- Brook M. M., Weinhouse E., Jarenwattananon M., Nudel D. B. Dilated cardiomyopathy complicating a case of epidermolysis bullosa dystrophica. Pediatr Dermatol. 1989 Mar;6(1):21–23. doi: 10.1111/j.1525-1470.1989.tb00261.x. [DOI] [PubMed] [Google Scholar]
- Haynes L., Atherton D. J., Ade-Ajayi N., Wheeler R., Kiely E. M. Gastrostomy and growth in dystrophic epidermolysis bullosa. Br J Dermatol. 1996 May;134(5):872–879. [PubMed] [Google Scholar]
- Järvikallio A., Pulkkinen L., Uitto J. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1). Hum Mutat. 1997;10(5):338–347. doi: 10.1002/(SICI)1098-1004(1997)10:5<338::AID-HUMU2>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
- Kothari S. S., Sharma M. L-carnitine in children with idiopathic dilated cardiomyopathy. Indian Heart J. 1998 Jan-Feb;50(1):59–61. [PubMed] [Google Scholar]
- Li G. S., Wang F., Kang D., Li C. Keshan disease: an endemic cardiomyopathy in China. Hum Pathol. 1985 Jun;16(6):602–609. doi: 10.1016/s0046-8177(85)80110-6. [DOI] [PubMed] [Google Scholar]
- Li Y., Nan B. S. Correlation of selenium, glutathione peroxidase activity and lipoperoxidation rates in dilated cardiomyopathy. Chin Med J (Engl) 1989 Sep;102(9):670–671. [PubMed] [Google Scholar]
- Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide. Jpn Circ J. 1997 Apr;61(4):275–291. doi: 10.1253/jcj.61.275. [DOI] [PubMed] [Google Scholar]
- Melville C., Atherton D., Burch M., Cohn A., Sullivan I. Fatal cardiomyopathy in dystrophic epidermolysis bullosa. Br J Dermatol. 1996 Oct;135(4):603–606. [PubMed] [Google Scholar]
- Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Dec;56(12):1088–1096. doi: 10.1001/archpsyc.56.12.1088. [DOI] [PubMed] [Google Scholar]
- Müller S. Dilatative Kardiomyopathie--Herzmuskelerkrankung unbekannter Ursache oder Autoimmunerkrankung? Neue Aspekte zur Atiologie, Pathogenese und Klinik. Z Gesamte Inn Med. 1989 Aug 15;44(16):469–476. [PubMed] [Google Scholar]
- Roe D. S., Terada N., Millington D. S. Automated analysis for free and short-chain acylcarnitine in plasma with a centrifugal analyzer. Clin Chem. 1992 Nov;38(11):2215–2220. [PubMed] [Google Scholar]
- Sharratt G. P., Lacson A. G., Cornel G., Virmani S. Echocardiography of intracardiac filling defects in infants and children. Pediatr Cardiol. 1986;7(4):189–194. doi: 10.1007/BF02093177. [DOI] [PubMed] [Google Scholar]
- Squarcia U., Agnetti A., Caffarra A., Cavalli C., Marbini A. Cardiomiopatia dilatativa da deficit primitivo di carnitina. Pediatr Med Chir. 1986 Mar-Apr;8(2):157–161. [PubMed] [Google Scholar]
- Uitto J., Pulkkinen L. Molecular complexity of the cutaneous basement membrane zone. Mol Biol Rep. 1996;23(1):35–46. doi: 10.1007/BF00357071. [DOI] [PubMed] [Google Scholar]
- Zales V. R., Benson D. W., Jr Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting. Pediatr Cardiol. 1995 Mar-Apr;16(2):76–78. doi: 10.1007/BF00796822. [DOI] [PubMed] [Google Scholar]